Johnson & Johnson (JNJ) Other Non-Current Liabilities (2009 - 2026)

Johnson & Johnson (JNJ) posted Other Non-Current Liabilities of $486.0 million for Q1 2026, little changed sequentially from $486.0 million in Q4 2025, and down 60.52% YoY from $1.2 billion in Q1 2025.

Johnson & Johnson (JNJ) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Other Non-Current Liabilities data on file, last reported at $486.0 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 60.52% year-over-year to $486.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $486.0 million (down 60.52% YoY) and the FY2025 annual result came in at $486.0 million, down 60.07% from the prior year.
  • Other Non-Current Liabilities was little changed at $486.0 million in Q1 2026 per JNJ's latest filing, from $486.0 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $10.3 billion in Q2 2025, with the low at $486.0 million in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $1.9 billion, with a median of $1.1 billion recorded in 2023.
  • Year-over-year, Other Non-Current Liabilities surged 722.36% in 2025 and tumbled 60.52% in 2026.
  • Johnson & Johnson's Other Non-Current Liabilities stood at $525.0 million in 2022, then surged by 108.0% to $1.1 billion in 2023, then grew by 11.45% to $1.2 billion in 2024, then sank by 60.07% to $486.0 million in 2025, then changed by 0.0% to $486.0 million in 2026.
  • Business Quant data shows JNJ's Other Non-Current Liabilities at $486.0 million in Q1 2026, $486.0 million in Q4 2025, and $9.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 486.00 Mn
Dec 28, 2025 486.00 Mn
Sep 28, 2025 9.93 Bn
Jun 29, 2025 10.26 Bn
Mar 30, 2025 1.23 Bn
Dec 29, 2024 1.22 Bn
Sep 29, 2024 1.22 Bn
Jun 30, 2024 1.25 Bn
Mar 31, 2024 1.11 Bn
Dec 31, 2023 1.09 Bn
Oct 1, 2023 1.18 Bn
Jul 2, 2023 1.14 Bn
Apr 2, 2023 1.14 Bn
Jan 1, 2023 1.12 Bn
Oct 2, 2022 525.00 Mn
Jul 3, 2022 536.00 Mn
Apr 3, 2022 486.00 Mn
Jan 2, 2022 533.00 Mn
Oct 3, 2021 613.00 Mn
Jul 4, 2021 593.00 Mn